A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions-Reference-Cited by-同舟云学术

A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions

Published:2013-08-07 Issue:8 Volume:8 Page:e71379
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Villanti Andrea C.,Jiang Yiding,Abrams David B.,Pyenson Bruce S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Tobacco use–United States, 1900–1999;MMWR Morb Mortal Wkly Rep,1999

2. CDC grand rounds: current opportunities in tobacco control;MMWR Morb Mortal Wkly Rep,2010

3. The Impact of Tobacco Control Programs on Adult Smoking;MC Farrelly;Am J Public Health,2008

4. American Cancer Society (2012) Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society.

5. National Cancer Institute (2012) SEER Cancer Statistics Review 1975–2009: U.S. National Institutes of Health. Available: http://www.seer.cancer.gov/csr/1975_2009_pops09/index.html. Accessed June 1 2012.

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of co-located, high intensity smoking cessation support within lung cancer screening: Findings from the Process Evaluation of the Yorkshire Enhanced Stop Smoking study;2024-07-18

2. Navigating the Pitfalls of Lung Cancer Screening: A Case Study on the Risks and Costs of Negative Screenings;Cureus;2024-05-07

3. Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815);Enfermedades infecciosas y microbiologia clinica (English ed.);2024-05

4. Estudio prospectivo para la detección precoz de carcinoma pulmonar en pacientes con infección por VIH (estudio GESIDA 8815);Enfermedades Infecciosas y Microbiología Clínica;2024-04

5. Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study;Frontiers in Oncology;2024-03-20